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Abstract 
Introduction: The aim of this investigation was to evaluate in vitro antibacterial activity of horse chestnut honey 
and acacia honey at different concentrations against clinical isolates of the β-hemolytic streptococci group A 
(BHS-A). Honey’s active compounds have multiple therapeutic effects and it is used as traditional medicine for 
treatment and prevention of various illnesses.  
Materials and methods: The antimicrobial effects of two honeys were tested on forty-four strains of BHS-A, 
isolated from the throat by a modified disk diffusion method. A bacterial suspension of BHS-A strains was plated 
onto Müller-Hinton agar with 5% defibrinated horse blood. Using a sterile 8 mm diameter cork borer, wells were 
cut in the agar and into each was introduced 100µL of the different concentrations of the honey solution (25 
%v/v, 50 %v/v, 75% v/v and 100%v/v). A disk of penicillin was added as the positive control. The plates were 
incubated aerobically for18-24 hours at 36 (± 1)°C and zones of inhibition were measured.  
Results: The average diameter of the inhibition zones of acacia honey (100 %v/v) was 12.48 mm ± 1.73 mm, for 
acacia honey (75 %v/v) it was 11.06 mm±1.24 mm and for horse chestnut honey (100 %v/v) it was 11.08 mm ± 
1.02 mm. The positive control showed the average diameter of 30.45 mm ± 3.21 mm. Statistical significance (p < 
0.05) was observed comparing the zone diameters of the acacia honey (100%) and antibiotic penicillin, and 
between the horse chestnut honey (100%) and antibiotic penicillin.  
Conclusion: Acacia and horse chestnut honeys exhibit limited but effective antibacterial activity upon clinical 
isolates of BHS-A. 
(Kotris I, Talapko J, Drenjančević D. Evaluation of Antibacterial Activity of Two Different Honeys against Clinical 
Isolates of β-hemolytic Streptococci Group A. SEEMEDJ 2017;1(1);67-73) 
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β-hemolytic streptococci group A (BHS-A) are 
the most common bacterial cause of 
tonsillopharyngitis. This microorganism can also 
cause acute otitis media, pneumonia, skin and 
soft-tissue infections; cardiovascular, 
musculoskeletal, and lymphatic infections, 
bacteremia and meningitis (1). Classic 
streptococcal tonsillopharyngitis has an acute 
onset; produces concurrent dysphagia, 
headache, and upon examination is 
characterized by intense tonsillopharyngeal 
erythema, white-yellow exudates, and 
tender/enlarged palatine tonsils. Patients with 
acute streptococcal tonsillopharyngitis should 
receive therapy with an antimicrobial agent in a 
dose and for a duration that is likely to eradicate 
the infecting organism from the pharynx. Most 
oral antibiotic therapy must be administered for 
the conventional 10 days to achieve maximal 
rates of pharyngeal eradication of BHS-A (2-3). 
Over the past decade, several research groups 
have focused their attention to the use of bee 
honey as a supplement therapy (4-6). The use of 
bee honey as a traditional remedy for microbial 
infections dates back to ancient times (7). 
Aristotle, c.350 BC recommended that bee 
honey collected in specific regions and seasons 
(and therefore presumably from different floral 
sources) can be used for the treatment of 
different ailments (8). Certain types of honey 
exhibit broad-spectrum antimicrobial activity 
and are effective against antibiotic resistant 
bacterial pathogens (9-13). The present study 
aimed to evaluate the antibacterial activity of 
two bee honey varieties (horse chestnut honey 
and acacia honey) onto forty-four clinical 
isolates of BHS-A. 
Materials and Methods 
Bacterial strain 
Forty-four clinical isolates of beta-hemolytic 
streptococci group A (BHS-A) were evaluated. 
All these clinical isolates were donated by the 
Microbiology Department of the Public Health 
Institute of the County Brodsko-Posavska. 
Isolates of BHS-A used in our study were 
collected from throat swabs and were positive 
to BHS-A. They were identified on the basis of 
zone diameter around a bacitracin disk (10 
µg/disk) as well as on susceptibility testing and 
by a latex agglutination slide test for the 
grouping of Streptococci of the Lancefield 
groups A, B, C, D, F and G from culture plates as 
recommended by CLSI (14). 
Honey samples and dilution of honey 
Two honey varieties were used: horse chestnut 
honey and acacia honey, which were purchased 
from the local market from local beekeepers. 
Because of the intensified viscosity of acacia 
honey, different concentrations were made in 
sterile distilled water: 25 % v/v, 50 % v/v, 75 % 
v/v. This was done by dissolving the respective 
volumes: 8.3 ml, 16.6 ml and 25 ml of acacia 
honey, into corresponding volumes of sterile 
distilled water to give a 33.33 ml preparation. 
These were the tested different concentrations 
in addition to non-diluted horse chestnut honey, 
acacia honey and penicillin disk as the control. 
Susceptibility testing of honey 
A bacterial suspension of BHS-A strains, equal to 
the McFarland standard of 0.5 was prepared in 
saline. With sterile swabs (Copan Italia S.p.A, 
Brescia, Italy -plain swab sterile), the suspension 
was coated onto a Müller-Hinton agar with 5% 
defibrinated horse blood. Using a sterile 8 mm 
diameter cork borer, five wells were cut in the 
agar and into each was introduced 100µL of the 
different concentrations of the honey solution. 
Into the place of the sixth well, a disk of penicillin 
was added as the positive control. The plates 
were incubated aerobically for18-24 hours at 36 
(± 1)°C and examined for zones of inhibition. The 
zones of inhibition were measured (in 
millimeters) and recorded. 
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Table 1. Inhibition zones of acacia honey and horse chestnut honey against beta-hemolytic streptococci group A (BHS-A) isolates. 
Beta-hemolytic streptococci 
group A isolates 






penicillin 100% 75% v/v 50% v/v 25% v/v 
BHS-A1 12 11 0 0 10 28 
BHS-A2 14 12 0 0 12 28 
BHS-A3 11 10 0 0 10 30 
BHS-A4 12 11 0 0 11 23 
BHS-A5 16 14 11 0 12 25 
BHS-A6 15 12 0 0 10 33 
BHS-A7 13 10 0 0 11 33 
BHS-A8 14 12 0 0 11 30 
BHS-A9 15 12 9 0 12 33 
BHS-A10 12 11 0 0 11 28 
BHS-A11 13 9 0 0 0 28 
BHS-A12 12 11 0 0 0 34 
BHS-A13 12 12 0 0 11 31 
BHS-A14 18 13 10 0 13 33 
BHS-A15 12 11 0 0 11 32 
BHS-A16 15 11 0 0 0 27 
BHS-A17 15 14 0 0 12 31 
BHS-A18 11 11 0 0 11 32 
BHS-A19 0 0 0 0 0 25 
BHS-A20 10 0 0 0 0 28 
BHS-A21 12 10 0 0 0 26 
BHS-A22 12 11 0 0 10 32 
BHS-A23 12 12 0 0 10 29 
BHS-A24 0 9 0 0 0 27 
BHS-A25 11 0 0 0 11 31 
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Statistical analysis  
Statistical analysis was performed using the 
program SigmaPlot Version 12.0. The differences 
observed between the groups were tested by 
multiple comparison procedures (Turkey test). 
The statistical significance level was confirmed 
at p < 0.05. 
Results 
The activity of acacia honey and horse chestnut 
honey against BHS-A isolates and the inhibitions 
zones are shown in Table 1. The average 
diameter of the inhibition zones of acacia honey 
(100 % v/v) on strains that were sensitive to the 
honey was 12.48 mm (standard deviation - SD = 
1.73 mm). The average diameter of the inhibition 
zones of acacia honey (75 % v/v) on strains that 
were sensitive to the honey was 11.06 mm (SD = 
1.24mm). Finally, the average diameter of the 
inhibition zones of horse chestnut honey (100 % 
v/v) on strains that were sensitive to the honey 
was 11.08 mm (SD = 1.02 mm). Antibiotic penicillin 
showed the average diameter of the inhibition 
zones to be 30.45 mm (SD = 3.21mm). Comparing 
the zone of inhibitions, by multiple comparison 
procedures, of different concentrations of 
BHS-A26 11 11 0 0 0 33 
BHS-A27 11 0 0 0 0 28 
BHS-A28 15 13 0 0 13 31 
BHS-A29 11 0 0 0 10 32 
BHS-A30 12 0 0 0 10 30 
BHS-A31 11 10 0 0 0 32 
BHS-A32 12 9 0 0 0 33 
BHS-A33 13 10 0 0 0 26 
BHS-A34 12 0 0 0 0 34 
BHS-A35 12 10 0 0 0 32 
BHS-A36 12 11 0 0 0 29 
BHS-A37 13 11 0 0 0 40 
BHS-A38 10 10 0 0 0 32 
BHS-A39 10 0 0 0 0 33 
BHS-A40 12 10 0 0 13 31 
BHS-A41 11 10 0 0 10 28 
BHS-A42 13 12 0 0 11 36 
BHS-A43 11 11 0 0 0 30 
BHS-A44 13 11 0 0 0 33 
*The zones of inhibition were measured in millimeters 
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honeys and penicillin (positive control), 
astatistically significant difference was observed 
with 100% acacia honey and100 % horse 
chestnut honey (p < 0.05). 
Discussion 
Honey has several properties that contribute to 
its antimicrobial activity. Low pH and high 
osmolarity are combined with the enzymatic 
production of hydrogen peroxide that exerts an 
antimicrobial effect (15-16). Hydrogen peroxide 
is the major contributor to the antimicrobial 
activity of honey (17). The different 
concentrations of this compound in different 
honeys result in their varying antimicrobial 
effects (7). 
In our research, we evaluated the antimicrobial 
activity of honey on BHS-A because, if in the 
case of positive antibacterial activity of honey on 
the BHS-A, it can be used primarily in the 
supportive therapy for e.g. tonsillopharyngitis. 
The use of honey is extremely uncomplicated 
and easily applicable.  
Researchers who evaluated the antimicrobial 
effect of honey showed that certain 
microorganisms have better sensitivity to it.  
Mittal et al. reported greater honey activity in 
vitro against Staphylococcus aureus, and 
Escherichia coli than on Pseudomonas 
aeruginosa (18). Cooper et al. reported honey 
activity on catalase negative, gram positive 
cocci (5); while Hannan et al. reported honey 
activity on typhoidal Salmonellae.  
When observing the antimicrobial activity of 
honey, the key element of effectiveness is the 
type of honey. Certain types of honey, such as 
Manuka honey, exhibit extensive antimicrobial 
activity. A group of researchers from Ireland and 
Australia reported that Manuka honey has 
clinical potential and a greater antimicrobial 
effect in vitro against Staphylococcus aureus, 
and Escherichia coli than on Pseudomonas 
aeruginosa (19, 20). A group of researchers from 
Cameroon focused on the antimicrobial activity 
of honeys on clinical isolates of Helicobacter 
pylori (6, 21, 22). The results of such research can 
provide alternative therapies against certain 
bacteria.  
In our research, it was observed that 100% of 
acacia honey and horse chestnut honey show 
maximum antimicrobial activity as shown in 
Table 1. When the concentrations of honey were 
50% v/v and 25% v/v there was not an 
antimicrobial effect. This conclusion of our study 
is inconsistent with the conclusion of other 
authors (6). It is assumed that such differences 
are due to the various kinds of honeys. 
In this study, in order to evaluate the 
antibacterial activity of two honey varieties 
(horse chestnut honey and acacia honey) upon 
clinical isolates of BHS-A, we concluded that 
honeys exhibit limited, but effective antibacterial 
activity. Such results support the use of honey as 
a supplement therapy for BHS-A infections e.g. 
tonsillopharyngitis. Further research is required 
to determine the in vivo activity of horse chestnut 
honey and acacia honey onto BHS-A.  
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